Standout Papers

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV 2019 2026 2021 2023 425
  1. Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV (2019)
    François Venter, Michelle Moorhouse et al. New England Journal of Medicine

Immediate Impact

2 from Science/Nature 56 standout
Sub-graph 1 of 22

Citing Papers

Mechanisms of long COVID and the path toward therapeutics
2024 Standout
A meta-analysis on the relationship between climate anxiety and wellbeing
2024 Standout
2 intermediate papers

Works of Lee Fairlie being referenced

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV
2019 Standout
Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial
2017

Author Peers

Author Last Decade Papers Cites
Lee Fairlie 1336 442 445 449 80 1.9k
Andrea Ciaranello 1472 545 486 248 128 2.1k
Jane C. Lindsey 1273 375 693 586 70 2.3k
Dhayendre Moodley 1624 781 540 322 117 2.4k
Guerino Chalamilla 1149 593 282 357 47 1.9k
Kennedy Otwombe 950 571 355 198 135 1.6k
John Farley 1529 760 563 449 63 2.4k
Seble Kassaye 1290 648 483 443 133 2.0k
Karen Cohen 1083 537 431 253 108 2.3k
William C. Holmes 1011 526 226 437 60 2.1k
Allison Zerbe 1383 729 289 227 76 1.8k

All Works

Loading papers...

Rankless by CCL
2026